Etamsylate (n=101) | Control (n=103) | |
Neuromotor impairment | ||
Tone changes in | ||
4 limbs | 8 | 2 |
3 limbs | 3 | 0 |
2 limbs | ||
Ipsilateral | 1 | 2 |
Contralateral | 3 | 4 |
1 limb | 1 | 1 |
Tone change present but unclassifiable | 1 | 3 |
No neuromotor impairment | 81 | 89 |
Not known | 3 | 4 |
Neuromotor impairment ± disability | ||
Impairment but no disability | 5 | 5 |
Moderate disability | 7 | 5 |
Severe disability | 5 | 2 |
Developmental status | ||
No delay | 87 | 85 |
Mild delay | 4 | 7 |
Moderate delay | 3 | 4 |
Severe delay | 5 | 3 |
Not known | 2 | 4 |
Vision\ocular problems | ||
Squint | 19 | 15 |
ROP | 3 | 1 |
Refractive error | 5 | 2 |
Other | 1 | 0 |
Normal vision | 90 | 88 |
Not fully corrected by glasses | 0 | 1 |
Low vision | 1 | 1 |
See light only or blind | 1 | 0 |
Not known | 9 | 13 |
Hearing | ||
Sensorineural hearing loss: | 1 | 0 |
Conductive hearing loss | 1 | 0 |
Hearing aids | 0 | 0 |
Seizures or on anticonvulsants | 3 | 3 |
Drug treatment | ||
Bronchodilators | 7 | 12 |
Other medication | 5 | 6 |
Weight | ||
<3rd centile | 20 | 17 |
3–10th centile | 16 | 18 |
10–90th centile | 56 | 50 |
>90th centile | 2 | 2 |
Not known | 7 | 16 |
Length | ||
<3rd centile | 18 | 22 |
3–10th centile | 18 | 14 |
10–90th centile | 58 | 56 |
>90th centile | 3 | 3 |
Not known | 4 | 8 |
Growth estimates based on Growth Foundation Standards (Cole TJ, Freeman JV, Preece MA. British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood. Stat Med1998;17:407–29).
ROP, Retinopathy of immaturity.